Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Goodwill & Intangibles: 2022-2024

Historic Goodwill & Intangibles for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Dec 2024 value amounting to $9.5 million.

  • Arcutis Biotherapeutics' Goodwill & Intangibles rose 57.02% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 57.02%. This contributed to the annual value of $9.5 million for FY2024, which is 47.24% up from last year.
  • According to the latest figures from FY2024, Arcutis Biotherapeutics' Goodwill & Intangibles is $9.5 million, which was up 47.24% from $6.4 million recorded in FY2023.
  • Over the past 5 years, Arcutis Biotherapeutics' Goodwill & Intangibles peaked at $9.5 million during FY2024, and registered a low of $6.4 million during FY2023.
  • In the last 3 years, Arcutis Biotherapeutics' Goodwill & Intangibles had a median value of $7.2 million in 2022 and averaged $7.7 million.
  • In the last 5 years, Arcutis Biotherapeutics' Goodwill & Intangibles declined by 10.43% in 2023 and then soared by 47.24% in 2024.
  • Arcutis Biotherapeutics' Goodwill & Intangibles (Yearly) stood at $7.2 million in 2022, then declined by 10.43% to $6.4 million in 2023, then skyrocketed by 47.24% to $9.5 million in 2024.